The weight-loss jab boom is in full swing. With celebrities showing off dramatic transformations, #ozempicbody trending on TikTok, and many buying GLP-1 drugs like Mounjaro, Wegovy and Ozempic to slim down for beach holidays, it’s estimated 1.5 million Britons are now using weight-loss drugs – with 95 per cent accessing them privately, from online pharmacies or weight-loss clinics.

There was good news recently for anyone hoping to try the latest weight-loss injections: the NHS announced that Mounjaro will now be available through GP surgeries in England for patients with severe obesity and the “highest clinical need”. Over the next three years, almost a quarter of a million people are expected to benefit.

GLP-1 drugs, originally designed to treat type-2 diabetes, are widely hailed

See Full Page